内镜下曲张静脉套扎术联合经颈静脉肝内门体静脉分流术治疗肝硬化食管胃底静脉曲张破裂出血患者效果研究*

doi:10.3969/j.issn.1672-5069.2024.02.020

摘要/Abstract

摘要： 目的观察采用内镜下曲张静脉套扎术(EVL)联合经颈静脉肝内门体静脉分流术(TIPS)治疗肝硬化并发食管胃底静脉曲张破裂出血(EVB)患者的效果。方法 2019年3月～2022年1月我院收治的85例肝硬化并发EVB患者, 其中42例对照组接受EVL术治疗, 43例观察组在接受EVL治疗后择期行TIPS治疗。随访6个月。采用超声检测门静脉压力梯度(PPG)、门静脉压力(PVP)和门静脉血流速度(PVFV), 采用ELISA法检测血清过氧化脂质(LPO)、胃动素(MTL)和胃泌素(GAS)水平。结果急性期, 观察组和对照组病死率分别为9.3%和9.5%(P>0.05);两组止血时间和输血量无显著性差异(P＞0.05), 而观察组住院日为(12.8±2.6)d, 显著长于对照组【(8.1±1.5)d, P＜0.05】;术后, 观察组PVFV为(16.7±3.8)cm/s, 显著快于对照组【(12.5±2.4), P＜0.05】, 而PPG和PVP分别为(9.1±1.4)mmHg和(19.6±2.3)mmHg, 均显著低于对照组【分别为(12.2±1.9)mmHg和(34.8±3.4)mmHg, P＜0.05】;观察组血清LPO、MTL和GAS水平分别为(4.1±2.2)U/L、(202.4±22.7)ng/L和(76.3±8.4)μg/mL, 均显著低于对照组【分别为(7.9±1.6)U/L、(256.8±26.1)ng/L和(115.6±10.9)μg/mL, P＜0.05】;随访6个月, 对照组和观察组再出血发生率分别为31.6%和7.7%(P＜0.05)。结论在实施EVL急性期止血后适时进行TIPS术治疗肝硬化并发EVB患者效果确切, 可减少再出血发生率, 值得进一步研究。

关键词: 肝硬化, 食管胃底静脉曲张破裂出血, 曲张静脉套扎术, 经颈静脉肝内门体静脉分流术, 再出血, 治疗

Abstract: Objective This clinical trial was conducted to investigate the efficacy of endoscopic variceal ligation (EVL) and transjugular intrahepatic portal vein shunt (TIPS) in the treatment of patients with liver cirrhosis (LC) and complicated esophagogastric variceal bleeding (EVB) . Methods 85 patients with LC and complicated EVB were enrolled in this study between March 2019 and January 2022, and 42 patients in control group received EVL and 43 patients in observation group received TIPS after EVL. All patients were followed-up for 6 months. The portal vein pressure gradient (PPG), portal vein pressure (PVP) and portal vein flow velocity (PVFV) were detected by ultrasonography, and serum lipid peroxide (LPO), motilin (MTL) and gastrin (GAS) levels were determined by ELISA. Results The fatality rates after first bleeding were 9.3% and 9.5%(P>0.05) in the observation and control groups; there was no significant differences as respect to the hemostasis time and blood transfusion volume between the two groups (P>0.05), while the hospital stay in the observation group was(12.8±2.6)d, much longer than in the control; one month after operation, the PVFV in the observation group was (16.7±3.8)cm/s, much faster than , while the PPG and PVP were (9.1±1.4)mmHg and (19.6±2.3)mmHg, both significantly lower than in the control; serum LPO, MTL and GAS levels in the observation were (4.1±2.2)U/L, (202.4±22.7)ng/L and (76.3±8.4)μg/mL, all much lower than [(7.9±1.6)U/L, (256.8±26.1)ng/L and (115.6±10.9)μg/mL, respectively, P＜0.05) in the control; at the end of six-month follow-up, the incidence of re-bleeding in the observation groups was 7.7%, much lower than 31.6%(P＜0.05) in the control. Conclusion The patients with decompensated LC receive TIPS after EVL is efficacious in preventing re-bleeding after first EVB, which is worthy of further investigation.

Key words: Liver cirrhosis, Esophagogastric variceal bleeding, Endoscopic variceal ligation, Transjugular intrahepatic portal shunt, Re-bleeding, Therapy

肖潇, 盛云建. 内镜下曲张静脉套扎术联合经颈静脉肝内门体静脉分流术治疗肝硬化食管胃底静脉曲张破裂出血患者效果研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 238-241.

Xiao Xiao, Sheng Yunjian. Efficacy of endoscopic variceal ligation and transjugular intrahepatic portal vein shunt in the treatment of patients with liver cirrhosis and complicated esophagogastric variceal bleeding[J]. Journal of Practical Hepatology, 2024, 27(2): 238-241.

参考文献

[1] Gines P, Krag A, Abraldes J G, et al. Liver cirrhosis. Lancet, 2021,398(10308):1359-1376.
[2] Shen Y, Ma W, Hang Y, et al. Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein. Exp Ther Med, 2021,21(5):442.
[3] Liu CH, Liu S, Zhao YB, et al. Development and validation of a nomogram for esophagogastric variceal bleeding in liver cirrhosis: A cohort study in 1099 cases. J Dig Dis, 2022,23(10):597-609.
[4] 戴欢,李凯,朱永湘,等. EVL和注射硬化剂治疗乙型肝炎肝硬化并发EVB患者疗效研究. 实用肝脏病杂志,2023,26(1):87-90.
[5] Wu W, Zhang H, Zeng Z, et al. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis. Scand J Gastroenterol, 2022,57(12):1494-1502.
[6] 中华医学会肝病学分会. 肝硬化诊治指南.实用肝脏病杂志,2019,22(6):770-792.
[7] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 中华内科杂志,2023,62(1):7-22.
[8] Gralnek IM, Camus DM, Garcia-Pagan JC, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 2022,54(11):1094-1120.
[9] Del RIJ, Ramos BC, Banares R, et al. Esophagogastric variceal bleeding as a debut of Caroli's syndrome. Rev Esp Enferm Dig, 2022,114(11):678.
[10] Chikamori F, Ito S, Sharma N. Percutaneous transhepatic obliteration for life-threatening bleeding after endoscopic variceal ligation in a patient with severe esophagogastric varices. Radiol Case Rep, 2023,18(2):624-630.
[11] Ma JL, Li P, Jiang L, et al. Long-term outcomes of hepatectomy or radiofrequency ablation associated with splenectomy for the treatment of hepatocellular carcinoma and esophagogastric variceal bleeding. Asian J Surg, 2022,45(8):1607-1609.
[12] Luo R, Gao J, Gan W, et al. Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis. World J Gastroenterol, 2023,29(6):1076-1089.
[13] 林秀清,吴伟,金瑞放,等. TIPS联合胃冠状静脉栓塞术治疗肝硬化门静脉高压症上消化道出血的疗效分析. 中华普通外科杂志,2019,34(3):217-221.
[14] Li J, Hu J, Li P, et al. Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study. Chin Med J (Engl), 2022,135(19):2319-2325.
[15] Miyoshi T, Hidaka M, Miyamoto D, et al. Successful induction of human chemically induced liver progenitors with small molecules from damaged liver. J Gastroenterol, 2022,57(6):441-452.
[16] Lv Y, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China. Liver Int, 2023,43(1):18-33.
[17] Chikamori F, Maeda A, Sharma N. An emergency hybrid procedure that combines endoscopic treatment with partial splenic embolization for bleeding esophagogastric varices J. Radiol Case Rep, 2022,17(5):1640-1645.
[18] Hou Y, Yu H, Zhang Q, et al. Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients. Diagn Pathol, 2023,18(1):29.
[19] Chen J, Wu Z, Gao H, et al. Association between air temperature and emergency admission for esophagogastric variceal bleeding: a case-crossover study in Beijing, China. BMC Gastroenterol, 2023,23(1):52.
[20] Wang C, Liu J, Yao J, et al. Transjugular intrahepatic portosystemic shunt in patients with autoimmune hepatitis-induced cirrhosis and variceal bleeding. Abdom Radiol (NY), 2022,47(4):1464-1472.

内镜下曲张静脉套扎术联合经颈静脉肝内门体静脉分流术治疗肝硬化食管胃底静脉曲张破裂出血患者效果研究^*

Efficacy of endoscopic variceal ligation and transjugular intrahepatic portal vein shunt in the treatment of patients with liver cirrhosis and complicated esophagogastric variceal bleeding

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐京杭, 于岩岩, 徐小元. 肝硬化临床研究进展[J]. 实用肝脏病杂志, 2024, 27(2): 161-164.
[2]	张舒茜, 谢雯. 有效白蛋白概念、检测及其临床应用前景^*[J]. 实用肝脏病杂志, 2024, 27(2): 165-168.
[3]	李兴泉, 杨春, 李诗源, 翁凯, 彭麟. 奥比帕利联合达塞布韦治疗基因1b型慢性丙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 177-180.
[4]	于欣欣, 付朝霞, 薛莉. 减量索磷布韦联合全量达卡他韦治疗终末期肾病合并急性丙型肝炎患者临床疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 181-184.
[5]	卜玲玲, 殷燕, 潘丹烨, 陈晨. 自身免疫性肝炎与原发性胆汁性肝硬化合并干燥综合征患者临床特征比较^*[J]. 实用肝脏病杂志, 2024, 27(2): 206-209.
[6]	李尧, 梁健, 张春, 董静, 陈照林, 周旭, 娄方明, 杨小康, 刘波, 宋海燕. 恩替卡韦联合聚乙二醇干扰素-α2b治疗代偿期乙型肝炎肝硬化患者疗效研究[J]. 实用肝脏病杂志, 2024, 27(2): 226-229.
[7]	王红霞, 胥晓倩, 于明帅. 内镜下硬化剂治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者应用不同剂量羟考酮联合丙泊酚靶控输注麻醉效果研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 230-233.
[8]	万贵香, 李忠廉, 赵亚博, 梁微微, 杜辉, 宁振海, 周媛, 万亮. 恩替卡韦联合扶正解毒散结方治疗乙型肝炎肝硬化患者疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 234-237.
[9]	朱春芬, 任春霖, 郭霞. 血清NT-ProBNP和TnI联合心电图检查早期诊断肝硬化性心肌病价值研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 242-245.
[10]	冯彦菲, 苏明华, 殷倩冰, 黎清梅, 苏土梅, 梁蘅恺, 韦璐, 黄建芳, 江建宁. 一组非肝硬化性门静脉高压症病因分析和诊断路径探讨^*[J]. 实用肝脏病杂志, 2024, 27(2): 246-250.
[11]	付彦爽, 陈晓丽, 付彦青, 冯静. MWA联合抗PD-1抗体治疗原发性肝癌患者疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 259-262.
[12]	杨帆, 杨军, 濮忠健, 胡雪星. TACE术后联合斑蝥酸钠维生素B6治疗原发性肝癌患者近期疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 263-266.
[13]	张亚龙, 胡冬梅, 赵晟, 孟海生. 超声引导下射频消融治疗小原发性肝癌疗效及死亡危险因素分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 271-274.
[14]	王秀香, 李海霞, 李辉, 王明月, 代树本, 于晓明. DEB-TACE序贯微波消融术治疗大原发性肝癌患者临床疗效研究^*[J]. 实用肝脏病杂志, 2024, 27(2): 283-286.
[15]	贾江坤, 余淼, 贾萌, 徐健, 王佳佳, 宋红霞, 申权, 薛焕洲, 陈旭晓. 腹腔镜辅助下血管瘤剥除术与解剖性肝切除术治疗巨大肝血管瘤疗效比较^*[J]. 实用肝脏病杂志, 2024, 27(2): 287-290.